FDA Inspection 1322456 — Hoxworth Blood Center University of Cincinnati Medical Center
The FDA completed an inspection of Hoxworth Blood Center University of Cincinnati Medical Center on June 16, 2026 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 16, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Cincinnati, OH (United States)